financetom
Business
financetom
/
Business
/
Moderna beats quarterly revenue estimates on COVID vaccine strength
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Moderna beats quarterly revenue estimates on COVID vaccine strength
Jul 31, 2026 4:22 AM

July 31 (Reuters) - Moderna ( MRNA ) beat Wall Street

estimates for second-quarter revenue on Friday benefiting from

better-than-expected sales of its COVID-19 vaccine, as the

company gears up for the potential launch of its flu shot.

The company reported second-quarter revenue of $145 million,

compared with analysts' average estimate of $103 million,

according to LSEG data.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved